Copyright
©2014 Baishideng Publishing Group Co.
World J Hepatol. Mar 27, 2014; 6(3): 114-129
Published online Mar 27, 2014. doi: 10.4254/wjh.v6.i3.114
Published online Mar 27, 2014. doi: 10.4254/wjh.v6.i3.114
Figure 3 A summary of key events and molecular pathways underlying GC-1 (A) and MB07811 (B) anti-steatotic and hypolipidemic effects (for details see the text).
TSH: Thyroid-stimulating hormone; T3: 3,3’,5-triiodo-L-thyronine; TRβ: Thyroid hormone receptor β isoform; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; FFA: Free fatty acid; TG: Triglyceride; T4: Thyroxine; Apo-C3: Apolipoprotein C3; mGPDH: Mitochondrial glycerol-3-phosphate dehydrogenase; CPT-1α: Carnitine palmitoyltransferase-1α.
- Citation: Coppola M, Glinni D, Moreno M, Cioffi F, Silvestri E, Goglia F. Thyroid hormone analogues and derivatives: Actions in fatty liver. World J Hepatol 2014; 6(3): 114-129
- URL: https://www.wjgnet.com/1948-5182/full/v6/i3/114.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i3.114